23.06.2023 • News • Enzene Biosciences • Biopharmaceutical • biopharmaceutical manufacturing

Enzene Biosciences Plans Biopharma Campus in USA

Indian CDMO Enzene Biosciences — a subsidiary of Alkem Laboratories — is to build a biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell, New Jersey, USA.

The facility will be Enzene’s first outside of India when it starts up in June 2024, initially employing 50 staff and expanding to 300 in the future.

Enzene said the New Jersey manufacturing capabilities will provide North American biopharmaceutical companies with streamlined supply chains, fast turnaround times, enhanced communication and greater control over the manufacturing process.

Located in Pune, Enzene is focused on producing biosimilars, novel biologics, synthetic peptides and phytopharmaceuticals.

Author: Elaine Burridge, Freelance Journalist

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.